Biotech Showcase

Save $200 by Fri. Dec. 5! Discount expires in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
An all-inclusive life science conference
January 12–14, 2026 | San Francisco, CAJanuary 20–21, 2026 | Digital Partnering

Michael Meyers
Vice Chairman, Head, M&A and Strategic Advisory Services at H.C. Wainwright & Co., LLC
Speaker

Profile

Michael Meyers has over 25 years of investment banking, venture capital, investment management and operating experience in healthcare, with an emphasis on the life sciences. Over the course of his career, Mr. Meyers has advised on ~ $150 billion in transaction value.

H.C. Wainwright & Co., LLC is an employee-owned corporate and institutional investment bank with an emphasis on the life sciences. We underwrite, place, arrange, structure and advise small, mid and large capitalization companies spanning corporate finance (equity, equity-linked, credit and royalties), M&A and licensing advisory. In 2024, we completed 305 transactions in support of our clients.

HCW maintains one of the largest fundamental equity research teams, with 20 senior publishing analysts covering ~ 500 publicly traded life sciences companies. In addition, HCW serves our clients across capital markets, placements, corporate access, investment and thematic conferences, and sales and trading.

Agenda Sessions

  • The Outlook for Biopharma Financing: Where is the Funding Going?

    12:00